Paul R. Sanberg PhD, DSc, FNAI
Dr. Paul R. Sanberg is the Senior Vice President for Research, Innovation& Economic Development, Distinguished University Professor, and the Executive Director of the Center of Excellence for Aging and Brain Repair at the University of South Florida, in Tampa, Florida, USA. His work has been instrumental in translating new pharmaceutical and cellular therapeutics to clinical trials and commercialization for Tourette syndrome, stroke, ALS, Alzheimer’s, Huntington’s, and Parkinson’s disease, and he has significant biotech and pharmaceutical industry experience in these areas.
A native of Florida, Dr. Sanberg has trained in Canada at York University and the University of British Columbia, as well as at the Australian National University and Johns Hopkins University School of Medicine, and has held faculty appointments at the University of Cincinnati and Brown University among others. He is an inventor on 42 U.S. and 70 foreign patents and he has served on numerous scientific advisory boards for health-related foundations and companies. He is the author of more than 600 scientific articles and 14 books, and is considered as a highly cited scientist, with more than 25,000 citations to his published work. He is the editor-in-chief of Technology and Innovation, Journal of the National Academy of Inventors, and serves on the editorial boards of more than 30 scientific journals.
Dr. Sanberg is the president and a Charter Fellow of the National Academy of Inventors and chair of the Florida Inventors Hall of Fame Advisory Board. He has served as president of a number of professional societies, including the American Society for Neural Transplantation and Repair, the Cell Transplant Society, and the International Behavioral Neuroscience Society.
He is the 2015 Medalist of the Florida Academy of Sciences and a Florida Inventors Hall of Fame Inductee. Further, he is a Fellow of the American Association for the Advancement of Science, the American Institute for Medical and Biological Engineering, and the Royal Societies of Chemistry, Public Health, and Medicine, as well as an AAAS-Lemelson Invention Ambassador. He also serves on the nomination evaluation committee of the United States National Medal of Technology and Innovation administered by the U.S. Department of Commerce, the Smithsonian Innovation Festival selection committee, and the advisory board of the APLU Commission on Innovation, Competitiveness, and Economic Prosperity.